Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 0.316 | uM | 72 | hr | 3 | 411 | 106 | 0.2995 | 0.2619 | 0.2579 | 0.2293 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 3 | 413 | 82 | 0.3351 | 0.4489 | 0.1985 | 0.1849 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 1 | 413 | 133 | 0.2835 | 0.2531 | 0.3220 | 0.3208 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 414 | 180 | 0.1442 | 0.1471 | 0.4348 | 0.4142 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 422 | 406 | 0.0029 | 0.0041 | 0.9621 | 0.9488 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 2 | 424 | 402 | 0.0040 | 0.0041 | 0.9481 | 0.9488 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 3 | 430 | 50 | 0.3732 | 0.6000 | 0.1163 | 0.1021 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 431 | 171 | 0.1602 | 0.1471 | 0.3968 | 0.4142 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 434 | 114 | 0.2553 | 0.2628 | 0.2627 | 0.2739 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 443 | 169 | 0.1688 | 0.2245 | 0.3815 | 0.3979 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 2 | 446 | 136 | 0.0983 | 0.1027 | 0.3049 | 0.2808 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 447 | 138 | 0.1008 | 0.1000 | 0.3087 | 0.3467 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 451 | 88 | 0.2780 | 0.2918 | 0.1951 | 0.1993 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 3 | 451 | 21 | 0.4354 | 0.6021 | 0.0466 | 0.0426 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 453 | 159 | 0.1811 | 0.1801 | 0.3510 | 0.3728 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 454 | 186 | 0.1651 | 0.1742 | 0.4097 | 0.4178 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 459 | 176 | 0.1744 | 0.1801 | 0.3834 | 0.3728 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 1.000 | 1.000 | uM | 72 | hr | 3 | 460 | 65 | 0.1252 | 0.3116 | 0.1413 | 0.1548 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 2 | 462 | 141 | 0.3152 | 0.3656 | 0.3052 | 0.2907 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 465 | 150 | 0.2413 | 0.2538 | 0.3226 | 0.3464 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 471 | 92 | 0.2903 | 0.2918 | 0.1953 | 0.1993 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 3 | 471 | 427 | 0.0079 | 0.0109 | 0.9066 | 0.8930 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 471 | 57 | 0.3171 | 0.4386 | 0.1210 | 0.1472 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 2 | 472 | 162 | 0.3139 | 0.3044 | 0.3432 | 0.3533 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 3 | 473 | 85 | 0.3810 | 0.4579 | 0.1797 | 0.1782 |